RAN-29 (Compound)

Pubchem:PUBCHEM:46238405

Id:23421a32-9245-5ece-81c3-1cd9e49c921c

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View RAN-29's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for RAN-29.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with RAN-29.

Results found

Linked to

	Label	Description
	RAN-29 negatively regulates CA12 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	RAN-29 negatively regulates ENPP2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	RAN-29 negatively regulates MT1E Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	RAN-29 positively regulates TGFBR3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	RAN-29 negatively regulates ANPEP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	RAN-29 positively regulates PIP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	RAN-29 in similarity relationship with atorvastatin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	RAN-29 positively regulates TOX3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	RAN-29 positively regulates TMEM45A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	RAN-29 negatively regulates MT2A Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS